Flow cytometric analysis of consecutive lymph node samples from patients with Hodgkin's disease: reproducible within one biopsy?
In Hodgkin's disease DNA aneuploidy is not a prognostic factor. However, the prognostic significance of DNA content in Hodgkin's disease may be missed by either intratumor DNA heterogeneity or DNA analysis of limited samples. For flow cytometry usually one section of 40-60 microns is used for the analysis. In breast cancer this proved to be insufficient. In Hodgkin's disease no data are available. Therefore, we examined if analysis of more sections does increase the yield of aneuploidy. Archival, formalin-fixed, parafin embedded tissues were used. From 13 patients four sections of 50 microns could be analysed for DNA content. In 12 of 13 patients the results were consistent in all four sections of one patient case; seven diploid, four aneuploid and one multiploid. In one case ploidy status changed: two sections were diploid and two were aneuploid. The DNA-index of the aneuploid samples ranged from 0.75 to 1.38 and varied from 0.02 to 0.14 within one case. The S-phase fraction remained constant within all evaluable cases (sd: 0.5-1.5%), except for one (sd: 4.7%). In conclusion, in Hodgkin's disease the ploidy status of the first section can be regarded to represent the whole tissue sample. Therefore, the absence of prognostic value of ploidy status is not explained by sampling errors in tissues analysed.
Pasman
P C
PC
University Hospital Maastricht, Department of Internal Medicine, The Netherlands.
Erdkamp
F L
FL
Breed
W P
WP
Janssen
W C
WC
Hoffmann
J J
JJ
Schutte
B
B
Vrints
L W
LW
Schouten
H C
HC
D001706:Biopsy; D004273:DNA, Neoplasm / Q000032:analysis* / Q000235:genetics*; D005434:Flow Cytometry; D006689:Hodgkin Disease / Q000235:genetics* / Q000473:pathology*; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D011003:Ploidies; D015203:Reproducibility of Results; D016196:S Phase / Q000502:physiology
D004273:DNA, Neoplasm